Back to top

Image: Shutterstock

Shopify, CVS Outperform in Q4, Plus COVID-19 Update

Read MoreHide Full Article

Wednesday, February 12, 2020

Deaths occurring due to the Wuhan-based coronavirus, currently referred to as COVID-19, has reached 1113 in mainland China, with 44,653 known cases in the country. This has officially made it a deadlier virus than the SARS epidemic from 18 years ago.

So why, with threats to the global economy tied at least somewhat to the spread of this disease, are pre-market futures trading up? Because the rate of new disease diagnoses is falling. This suggests COVID-19 may at least be being brought under control, limiting the damage it might do to the world economy.

This week is a relatively slow one for new economic data, although we do expect a new read on the Federal Budget for January today at 2pm ET. For December, this budget headline reached $9 billion. On Tuesday, new job openings for December came in lighter than expected: 6.4 million versus 6.8 million estimated.

Fed Chair Jay Powell continues his testimony on Capitol Hill today; if yesterday’s words from the head of the Federal Reserve is any indication, no notable surprises are expected. For instance, regarding COVID-19, Powell said that the disease could pose a threat to global growth. He made sure to mention economic growth in the U.S. remains strong, however.

CVS Health (CVS - Free Report) outperformed expectations in its Q4 earnings report released early this morning, topping earnings projections by 5 cents to $1.73 per share on $66.9 billion in sales, ahead of the $64.22 billion anticipated and representing 23% growth year over year. CVS has not missed its earnings consensus since Q3 2015, and full-year estimates have been raised to $7.04-7.17 per share. The stock is up 0.8% on the news in today’s pre-market.

Shopify (SHOP - Free Report) also impressed investors with a big beat on both top and bottom lines: 43 cents per share versus 23 cents expected, on $505.2 million which easily surpassed the Zacks consensus $482.3 million. Big growth in Gross Merchandizer Volume (GMV, a key metric in Shopify’s business model) was a major catalyst to company outperformance. Shares have climbed nearly 14% on the news this morning.

Mark Vickery
Senior Editor

Questions or comments about this article and/or its author? Click here>>

Zacks Top 10 Stocks for 2020

In addition to the stocks discussed above, would you like to know about our 10 finest buy-and-hold tickers for the entirety of 2020?

Last year's 2019 Zacks Top 10 Stocks portfolio returned gains as high as +102.7%. Now a brand-new portfolio has been handpicked from over 4,000 companies covered by the Zacks Rank. Don’t miss your chance to get in on these long-term buys.

Access Zacks Top 10 Stocks for 2020 today >>

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

The full Ahead Of Wall Street article

CVS Health Corporation (CVS) - free report >>

Shopify Inc. (SHOP) - free report >>

Published in